Diabetic nephropathy (DN) is a chronic microvascular complication of diabetes mellitus (DM), which is also the main cause of end-stage renal disease (ESRD). The prevalence rate of DM related chronic kidney disease (CKD) has exceeded that of glomerulonephritis (GN) related CKD. DN has become a big social problem for Chinese residents. The main treatment options for DN are lifestyle change and drug therapy, but currently common drugs can only reduce symptoms and delay disease progression, and new drugs are needed to improve the overall outcome of DN patients. Endothelin receptor antagonist (ERA), a new class of drugs used in DN in recent years, has shown good effects. This article summarized the clinical research progress of ERA in the treatment of DN, aiming to provide reference for clinical practice.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |